U.S. markets open in 2 hours 55 minutes
  • S&P Futures

    4,154.75
    -14.25 (-0.34%)
     
  • Dow Futures

    34,195.00
    -123.00 (-0.36%)
     
  • Nasdaq Futures

    13,336.25
    -50.75 (-0.38%)
     
  • Russell 2000 Futures

    2,204.90
    -17.80 (-0.80%)
     
  • Crude Oil

    65.27
    -0.10 (-0.15%)
     
  • Gold

    1,850.10
    +12.00 (+0.65%)
     
  • Silver

    27.74
    +0.37 (+1.35%)
     
  • EUR/USD

    1.2168
    +0.0022 (+0.18%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    20.43
    -2.70 (-11.67%)
     
  • GBP/USD

    1.4113
    +0.0011 (+0.08%)
     
  • USD/JPY

    109.1070
    -0.2400 (-0.22%)
     
  • BTC-USD

    45,092.10
    -4,254.79 (-8.62%)
     
  • CMC Crypto 200

    1,256.37
    -102.19 (-7.52%)
     
  • FTSE 100

    6,999.65
    -43.96 (-0.62%)
     
  • Nikkei 225

    27,824.83
    -259.67 (-0.92%)
     

Alkermes to Take Part in Stifel's 3rd Annual CNS Day

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, March 25, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at Stifel's 3rd Annual CNS Day on Thursday, Apr. 1, 2021 at 8:30 a.m. ET (1:30 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-stifels-3rd-annual-cns-day-301256281.html

SOURCE Alkermes plc